Literature DB >> 32040891

Assessing and responding to stress related to pulmonary function testing in cystic fibrosis through quality improvement.

Kelsey Nusbaum1, Stephanie S Filigno1,2, Julie Feldstein3, Elizabeth Hente3, Elizabeth Koch3, Lisa Mullen3, Jeanne Weiland3, Thomas Boat1,3, Christopher Siracusa1,3.   

Abstract

BACKGROUND: Pulmonary function tests (PFTs) are performed routinely to evaluate lung function in patients with cystic fibrosis (CF). Staff at the Cincinnati Children's Hospital Medical Center CF Center observed stress in patients before PFTs. An interdisciplinary quality improvement (QI) team was assembled to address this clinical issue.
METHODS: The Plan-Do-Study-Act method of QI was used to investigate feasibility of assessing stress and offering brief interventions to reduce stress before PFTs. Interventions included listening to music, covering the PFT screen, or doing breathing meditation before PFTs. Patients rated stress levels on a 1 to 5 Likert scale before and after testing.
RESULTS: Of 75 patient encounters, interventions were trialed in 20. Fifteen patients who tried an intervention reported wanting to use the intervention again (five encounters had missing data); patients reported that the intervention benefited performance on PFTs in eight encounters (40%). The average pre-PFT stress rating for encounters that trialed an intervention was 2.1 and post-PFT rating was 2.0. Average stress pre-PFT and post-PFT ratings were 1.7 and 1.6 respectively, for encounters that did not trial an intervention. Median length of PFT encounter was 15  minutes regardless of whether intervention was trialed.
CONCLUSION: Some patients with CF utilized interventions, while many opted out. This QI effort identified feasible outpatient clinic interventions that did not negatively impact clinic flow. Finding ways to reduce stress associated with PFTs could have a meaningful impact on patient performance and emotional well-being for a subset of patients.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  behavioral health; procedural anxiety; stress management

Mesh:

Year:  2020        PMID: 32040891      PMCID: PMC8864550          DOI: 10.1002/ppul.24673

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  13 in total

Review 1.  Measurement of stress.

Authors:  Frances Figueroa-Fankhanel
Journal:  Psychiatr Clin North Am       Date:  2014-10-11

Review 2.  ECFS best practice guidelines: the 2018 revision.

Authors:  Carlo Castellani; Alistair J A Duff; Scott C Bell; Harry G M Heijerman; Anne Munck; Felix Ratjen; Isabelle Sermet-Gaudelus; Kevin W Southern; Jurg Barben; Patrick A Flume; Pavla Hodková; Nataliya Kashirskaya; Maya N Kirszenbaum; Sue Madge; Helen Oxley; Barry Plant; Sarah Jane Schwarzenberg; Alan R Smyth; Giovanni Taccetti; Thomas O F Wagner; Susan P Wolfe; Pavel Drevinek
Journal:  J Cyst Fibros       Date:  2018-03-03       Impact factor: 5.482

3.  Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement.

Authors:  Bruce H Culver; Brian L Graham; Allan L Coates; Jack Wanger; Cristine E Berry; Patricia K Clarke; Teal S Hallstrand; John L Hankinson; David A Kaminsky; Neil R MacIntyre; Meredith C McCormack; Margaret Rosenfeld; Sanja Stanojevic; Daniel J Weiner
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

4.  Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis.

Authors:  Maria T Britto; Uma R Kotagal; Richard W Hornung; Harry D Atherton; Joel Tsevat; Robert W Wilmott
Journal:  Chest       Date:  2002-01       Impact factor: 9.410

5.  Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis.

Authors:  P A de Jong; A Lindblad; L Rubin; W C J Hop; J C de Jongste; M Brink; H A W M Tiddens
Journal:  Thorax       Date:  2005-10-21       Impact factor: 9.139

Review 6.  Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher.

Authors:  Rhonda Szczesniak; Sonya L Heltshe; Sanja Stanojevic; Nicole Mayer-Hamblett
Journal:  J Cyst Fibros       Date:  2017-01-20       Impact factor: 5.482

7.  Quality of life in young people with cystic fibrosis: effects of hospitalization, age and gender, and differences in parent/child perceptions.

Authors:  M Hegarty; J Macdonald; P Watter; C Wilson
Journal:  Child Care Health Dev       Date:  2008-10-30       Impact factor: 2.508

Review 8.  Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.

Authors:  Patrick A Flume; Peter J Mogayzel; Karen A Robinson; Christopher H Goss; Randall L Rosenblatt; Robert J Kuhn; Bruce C Marshall
Journal:  Am J Respir Crit Care Med       Date:  2009-09-03       Impact factor: 21.405

Review 9.  Systematic review of the application of the plan-do-study-act method to improve quality in healthcare.

Authors:  Michael J Taylor; Chris McNicholas; Chris Nicolay; Ara Darzi; Derek Bell; Julie E Reed
Journal:  BMJ Qual Saf       Date:  2013-09-11       Impact factor: 7.035

10.  Assessing and responding to stress related to pulmonary function testing in cystic fibrosis through quality improvement.

Authors:  Kelsey Nusbaum; Stephanie S Filigno; Julie Feldstein; Elizabeth Hente; Elizabeth Koch; Lisa Mullen; Jeanne Weiland; Thomas Boat; Christopher Siracusa
Journal:  Pediatr Pulmonol       Date:  2020-02-10
View more
  1 in total

1.  Assessing and responding to stress related to pulmonary function testing in cystic fibrosis through quality improvement.

Authors:  Kelsey Nusbaum; Stephanie S Filigno; Julie Feldstein; Elizabeth Hente; Elizabeth Koch; Lisa Mullen; Jeanne Weiland; Thomas Boat; Christopher Siracusa
Journal:  Pediatr Pulmonol       Date:  2020-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.